OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
Publish Date Publish Date | Title Title | Period End Date Period End Date | Status Status |
---|---|---|---|
03/14/2022 | Quarterly Report - information and disclosure | 01/31/2022 | A |
02/26/2022 | Attorney Letter with Respect to Current Information | 10/31/2021 | A |
02/26/2022 | Annual Report - Amended Disclosure and Information Statement | 10/31/2021 | A |
01/27/2022 | Notification of Late Filing | 10/31/2021 | A |
09/28/2021 | Quarterly Report - Disclosure and Information | 07/31/2021 | A |
06/15/2021 | Quarterly Report - Disclosure and Information | 04/30/2021 | A |
04/12/2021 | Quarterly Report - April 2020 | 04/30/2020 | A |
03/17/2021 | Quarterly Report - Disclosure and Information | 01/31/2021 | A |
02/23/2021 | Attorney Letter with Respect to Current Information | 10/31/2020 | A |
02/19/2021 | Annual Report - Disclosure and Information | 10/31/2020 | A |
No insider disclosure available for PASO.
No SEC transactions available for PASO.